Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of metformin oral solution, extended-release oral suspension, and tablets in children 10 to 16 years of age
Thus, the cytotoxicity profile of SR18 was evaluated by recruiting HeLa and HEK293 cell lines
Potential risks include growth hormone's counter-regulatory effects on glucose metabolism that may oppose tirzepatide's benefits, additive gastrointestinal symptoms, and growth hormone-related adverse effects such as edema and joint pain
Consent for publication If the manuscript is accepted, I agree to its publication in Diabetology and Metabolic Syndrome
The primary endpoint was HbA1c change from baseline to 24 weeks, and secondary endpoints included change in HbA1c and bodyweight at 36 weeks
market until at least 2032 so price will continue to be an issue